Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220837 · ClinicalTrials.gov registry record · NA
Online Learning Module to Advance Research Related to People With Disabilities
A NA study of Intellectual Disability and Developmental Disability, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07220837: Recruiting NA study of Intellectual Disability and Developmental Disability, sponsored by Albert Einstein College of Medicine.
NCT07220837 is a NA study of Intellectual Disability and Developmental Disability that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 200 participants, below the 346-participant average among 26 other Intellectual Disability trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220837, a NA study of Intellectual Disability and Developmental Disability, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will measure the effects of a brief one-time eLearning intervention on researcher Knowledge, Attitudes, and Perceptions (KAP) of including people with disabilities (PWDs) in biomedical \& behavioral research. Researchers will be recruited from across the Einstein/Montefiore network, and other medical centers with a focus on CTSAs.
Primary Outcome
Change in Attitudes will be assessed using the 16 item Attitudes to Disability Scale (ADS). Scoring range on a 5-point Likert scale ranging from 1-5, yielding an overall possible scoring range of 16-80. Participants for whom a single item is inapplicable (i.e., N/A) will have data removed for that item. Lower scores indicate less favorable attitudes towards people with disabilities, while higher scores indicate more favorable attitudes. \*Note: Questions 1-6 \& 11-16 are reverse coded.
Conditions Studied
Interventions
- OTHER Control
- OTHER eLearning module
Study Locations (1)
New York
- Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT07220837 shows while recruiting
NCT07220837 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 346-participant average among 26 other Intellectual Disability trials with a reported enrollment target (42% lower).
The record links to 3 conditions, with Intellectual Disability appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT07220837 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07220837 about?
NCT07220837 is a clinical study titled "Online Learning Module to Advance Research Related to People With Disabilities". This study will measure the effects of a brief one-time eLearning intervention on researcher Knowledge, Attitudes, and Perceptions (KAP) of including people with disabilities (PWDs) in biomedical \& behavioral research. Researchers will be recruited from across the Einstein/Montefiore network, and o...
What is the current status of trial NCT07220837?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-12-16. Estimated completion is 2026-02.
What conditions does trial NCT07220837 study?
This clinical trial studies the following conditions: Intellectual Disability, Developmental Disability, Disability.
What interventions are being tested in trial NCT07220837?
The interventions under investigation include: Control (OTHER), eLearning module (OTHER).
Who is sponsoring clinical trial NCT07220837?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220837 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intellectual Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07220837's enrollment target sits among peer trials
200 11th of 26 higher than 16 of 26 other Intellectual Disability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth
RECRUITING · NA
-
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
RECRUITING · NA
-
Harnessing Communication Preferences
RECRUITING · NA
-
Testing an Evidence-Based Supported Employment Model in Autistic Young Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI